Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Drug Designing: Open Access : Citations & Metrics Report

Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Drug Designing: Open Access.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total published articles	22	32	30	31	67	2	5	16	18	12	14	24	6
Research, Review articles and Editorials	0	2	2	24	33	0	4	15	15	12	10	25	6
Research communications, Review communications, Editorial communications, Case reports and Commentary	14	30	27	7	35	2	1	1	3	0	4	3	0
Conference proceedings	0	5	5	0	0	0	124	81	41	56	0	0	58
Citations received as per Google Scholar, other indexing platforms and portals	45	51	54	62	43	41	41	23	48	16	10	5	0

Journal total citations count	456
Journal impact factor	1.70
Journal 5 years impact factor	1.5
Journal cite score	1.57
Journal h-index	9
Journal h-index since 2019	7

Important citations (297)

Effect of thyroid hormones on glucose homeostasis View at Publisher View at Google Scholar View at Indexing
Tablets manufacturing methods and granulation techniques View at Publisher View at Google Scholar View at Indexing
Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design View at Publisher View at Google Scholar View at Indexing
Analytical similarity assessment in biosimilar studies. View at Publisher View at Google Scholar View at Indexing
Challenging issues in assessing analytical similarity in biosimilar studies View at Publisher View at Google Scholar View at Indexing
Statistical considerations in demonstrating cmc analytical similarity for a biosimilar product View at Publisher View at Google Scholar View at Indexing
Statistical approaches to assess biosimilarity from analytical data View at Publisher View at Google Scholar View at Indexing
On the establishment of equivalence acceptance criterion in analytical similarity assessment. View at Publisher View at Google Scholar View at Indexing
Sample size requirement in analytical studies for similarity assessment. View at Publisher View at Google Scholar View at Indexing
On the glycosylation aspects of bio similarity View at Publisher View at Google Scholar View at Indexing
Pragmatic rules for comparability of biological medicinal products. View at Publisher View at Google Scholar View at Indexing
on statistical approaches for demonstrating analytical similarity in the presence of correlation View at Publisher View at Google Scholar View at Indexing
Potent biological agent benzimidazole–a review View at Publisher View at Google Scholar View at Indexing
Synthesis and biological evaluation of some new benzimidazole derivatives bearing dithiocarbamate moiety as potential cholinesterase inhibitors View at Publisher View at Google Scholar View at Indexing
A review on recent publications using microwaves in synthesis of biologically active molecules View at Publisher View at Google Scholar View at Indexing
Acetylcholine esterase inhibitory potential of some benzimidazole derivatives View at Publisher View at Google Scholar View at Indexing
Statistical and regulatory considerations in assessments of interchangeability of biological drug products. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next »

Top